Evidence map›Paper›PMID 29420558›Full record

ArticlePloS one2018

Divalent cations are dispensable for binding to DNA of a novel positively charged olivomycin A derivative.

Artemy D Beniaminov, Lyubov G Dezhenkova, Olga K Mamaeva, Anna K Shchyolkina, Anna N Tevyashova, Dmitry N Kaluzhny, Alexander A Shtil

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Artemy D BeniaminovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
Lyubov G DezhenkovaGause Institute of New Antibiotics, Moscow, Russian Federation.
Olga K MamaevaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
Anna K ShchyolkinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
Anna N TevyashovaGause Institute of New Antibiotics, Moscow, Russian Federation.
Dmitry N KaluzhnyEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.ORCID 0000-0001-7090-3334
Alexander A ShtilN.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation.
Engelhardt Institute of Molecular Biology · RUD. Mendeleyev University of Chemical Technology of Russia · RUGause Institute of New Antibiotics Russian Academy of Medical Sciences · RUITMO University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current model of binding of the antitumor antibiotic olivomycin A (1) to GC-rich DNA regions presumes that coordination of the magnesium divalent cation with drug dimers is necessary for binding of 1 into the minor groove of the DNA duplex. Previously we have synthesized the derivatives of 1 termed 'short acid' (2) and its N,N-dimethylaminoethylamide (3). The latter compound demonstrated an improved tolerance in vivo compared to 1 and good therapeutic potency in animal models. We herein report that compound 3 is able to form stable complexes with DNA in the absence of Mg2+, in striking contrast to 1 whose binding to the DNA absolutely requires Mg2+. The mode of binding of 3 to DNA is similar in the presence or absence of Mg2+ as determined by circular dichroism. The affinity to DNA of 3 in Mg2+-free solution was similar to that of 1 or 3 in the presence of Mg2+ at low ionic strength. Non-electrostatic contributions to total free energy of binding of 1 and 3 to DNA were comparable for Mg2+-free complexes. Our data strongly suggest that electrostatic interaction of the positively charged 3 can compensate for the absence of divalent ions in complexes with DNA. This new property of the olivomycin A derivative expands the mechanistic knowledge of the modes of interaction with DNA of small molecular weight drug candidates.

Indexed as

Binding SitesCations, DivalentCircular DichroismDNAElectrophoresis, Agar GelOlivomycinsSpectrometry, FluorescenceStatic ElectricityCations, DivalentDNAolivomycin AOlivomycins

Identifiers

PMID29420558
PMCPMC5805246
OpenAlexW2791464353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.